Profile picture

Doctor Kenneth Chan

John Radcliffe Hospital, Oxford (United Kingdom of Great Britain & Northern Ireland)
Follow
Logo ESC

Contributor content

Case 2: a 55-year-old woman, borderline 10-year ASCVD risk, hesitant about lifelong statins.
Presentation
Case 2: a 55-year-old woman, borderline 10-year ASCVD risk, hesitant about lifelong statins.
Read more
AI-FAI scoring from routine computed tomography scans
Presentation
AI-FAI scoring from routine computed tomography scans
Read more
Coronary and systemic inflammation: the ORFAN study
Presentation
Coronary and systemic inflammation: the ORFAN study
Read more
AI-enhanced detection of coronary inflammation predicts 10-year risk for cardiac mortality and MACE in individuals with no or minimal coronary atherosclerosis on routine CCTA
Presentation
AI-enhanced detection of coronary inflammation predicts 10-year risk for cardiac mortality and MACE in individuals with no or minimal coronary atherosclerosis on routine CCTA
Read more
Coronary inflammation stratifies risk in patients undergoing coronary CT angiography: the Oxford Risk Factors and Non-Invasive Imaging (ORFAN) study
Presentation
Coronary inflammation stratifies risk in patients undergoing coronary CT angiography: the Oxford Risk Factors and Non-Invasive Imaging (ORFAN) study
Read more
Number of inflamed coronary vessels in prediction of cardiac death and MACE among patients undergoing routine CCTA: the Oxford Risk Factors And Non-Invasive Imaging (ORFAN) Study
Presentation
Number of inflamed coronary vessels in prediction of cardiac death and MACE among patients undergoing routine CCTA: the Oxford Risk Factors And Non-Invasive Imaging (ORFAN) Study
Read more
Dramatic reversal of dilated cardiomyopathy caused by severe hypocalcaemia
Presentation
Dramatic reversal of dilated cardiomyopathy caused by severe hypocalcaemia
Read more
Diamond-Forrester risk model and chest pain typicality in assessment of stable coronary artery disease
Presentation
Diamond-Forrester risk model and chest pain typicality in assessment of stable coronary artery disease
Read more

ESC 365 is supported by

novartis Explore sponsored resources